The Hamad Medical Corporation (HMC) recently held the Medication Safety Symposium 2017 to build on improving patient safety in the region by focusing on medication safety best practice and continuous quality improvement.
The symposium, which was endorsed by the International Medication Safety Network and Institutes for Safe Medication Practices US and Canada, attracted more than 350 delegates.
The HMC Medication Safety Symposium 2017 brought together a group of regional experts and leaders in the field of medication safety.
Speakers from a variety of healthcare sectors spoke about the best medication safety practices in the region, pharmacovigilance and its importance to Qatar, medication use research and several other patient safety initiatives.
Key speakers included Dr Rabih Dabliz, manager for quality and medication safety services at Cleveland Clinic Abu Dhabi; Dr Adel Alharf, executive director of the vigilance and benefit/risk assessment directorate at the Saudi Food and Drug Authority; and Dr Amr Saad, former associate minister of health for pharmaceutical affairs and founder of the Egyptian Pharmaceutical Vigilance Centre.
Dr Moza al-Hail, executive director of pharmacy at HMC, said: “This symposium was a great opportunity for healthcare providers, researchers and aspiring pharmacists in Qatar to come together and engage in discussions on medication safety to stimulate enhanced health outcomes.
“The symposium consolidates HMC’s commitment to providing the safest, most effective and most compassionate care to each and every one of our patients, giving delegates the chance to identify the best medication safety strategies and learn innovative ways of ensuring the safe use of medications.”
HMC
